TABITHA PITTMAN: Open Payments
NPI 1184203192 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 20 payments from 10 companies in 2025. Trend: 2023 $406 · 2024 $92 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| ABBVIE INC. | 4 | $59 |
| Novo Nordisk Inc | 4 | $58 |
| Lilly USA, LLC | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: CAPLYTA, JARDIANCE, VRAYLAR, Jornay PM, Dexcom G6 Transmitter, INGREZZA, XIFAXAN, LINZESS.
Industry payments across IN — which companies pay providers there.
